Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Regeneron Pharmaceuticals
(NQ:
REGN
)
893.47
-13.07 (-1.44%)
Streaming Delayed Price
Updated: 1:16 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Regeneron Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
This Market-Beating Stock Just Gave Investors More Reasons to Invest
October 05, 2023
There is a lot going the way of this biotech giant right now.
Via
The Motley Fool
Here's the Best Big Pharma Stock of the Decade so Far (and It's Not Even Close)
October 05, 2023
This stock puts the "big" in big pharma after massive gains in recent years.
Via
The Motley Fool
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
October 04, 2023
Via
Benzinga
MAIA Secures FDA Clearance Of IND Application For THIO For Non-Small Cell Lung Cancer
October 03, 2023
MAIA Biotechnology, Inc. (AMEX: MAIA) announced that the U.S.
Via
Benzinga
Exposures
Product Safety
Regeneron Pharmaceuticals Unusual Options Activity
October 03, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Via
Benzinga
Examining the Quality Attributes of NASDAQ:REGN.
September 22, 2023
Why the quality investor may take a look at REGENERON PHARMACEUTICALS (NASDAQ:REGN).
Via
Chartmill
Analyst Expectations for Regeneron Pharmaceuticals's Future
September 21, 2023
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
September 18, 2023
Via
Benzinga
Stock Split Watch: Is Regeneron Pharmaceuticals Next?
September 30, 2023
If the biotech does split its stock, it will be a first for the company.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 28, 2023
Via
Benzinga
Three Of Our Top Picks For Your Healthcare Portfolio
September 26, 2023
Amidst macro uncertainty, healthcare stocks should outperform.
Via
Talk Markets
This Recent FDA Approval Could Give Regeneron's Top Line a Big Boost
September 20, 2023
A higher-dose version of Eylea will help the company fight off competition and increase revenue.
Via
The Motley Fool
Exposures
Product Safety
3 Stocks to Buy to Ride Europe’s Coming Market Surge
September 19, 2023
With Europe’s markets looking to perform better in the second half of 2023, here are three European stocks to buy to ride the wave.
Via
InvestorPlace
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
September 14, 2023
Via
Benzinga
Check Out What Whales Are Doing With REGN
September 08, 2023
Via
Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,000 Today
September 05, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2023
September 15, 2023
Via
Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care....
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity
August 30, 2023
Via
Benzinga
Check Out What Whales Are Doing With REGN
August 25, 2023
Via
Benzinga
Is Regeneron Stock a Buy Now?
August 25, 2023
The company's growth fuel isn't running out yet.
Via
The Motley Fool
New to Investing? Here's How You Can Get Started With $500.
September 10, 2023
You don't have to invest a lot to start building a winning portfolio.
Via
The Motley Fool
3 Unstoppable Growth Stocks to Buy Right Now
September 09, 2023
These healthcare stocks show no signs of slowing down.
Via
The Motley Fool
2 Top Biotech Stocks to Buy in September
September 08, 2023
There is rarely a bad time to buy stocks with massive upside potential.
Via
The Motley Fool
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
September 05, 2023
Novartis expects to submit regulatory applications for its biosimilar soon.
Via
The Motley Fool
Is REGENERON PHARMACEUTICALS (NASDAQ:REGN) suited for quality investing?
September 01, 2023
This article explores why quality investors may have a look at REGENERON PHARMACEUTICALS (NASDAQ:REGN)
Via
Chartmill
Small Cancer Therapy Player Celularity To Provide Research Support For Regeneron's Therapy
August 29, 2023
Celularity Inc (NASDAQ: CELU) shares are trading higher after the company announced a multi-year Research Collaboration Services Agreement with Regeneron Pharmaceuticals Inc (NASDAQ: REGN).
Via
Benzinga
Wall Street Thinks This Tiny Biotech Company Could Soar Soon
August 28, 2023
An upcoming regulatory decision could prove to be an inflection point in the biotech's life cycle.
Via
The Motley Fool
These Are the ONLY 7 Penny Stocks to Consider in August 2023
August 26, 2023
These are just a few of the most promising penny stocks to consider as we head into the final months of the year.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.